Form 4 for AIM AIM ImmunoTech Inc.
Accepted 2026-09-16 09:15:22 ET · period of report 2026-09-15 · accession 0001493152-26-042848 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-16 09:15 | 2026-09-15 | AIM | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.221 | +22.0K | 91.8K | +32% | +$4,862 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-15 | P | A | 22,000 | $0.221 | 91,822 | D | — | — |